First line treatment with subcutaneous efgartigimod in impending myasthenic crisis: a case report
In acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (gMG), neonatal Fc-receptor (FcRn) inhibition has broadened the therapeutic spectrum. Myasthenic crisis (MC), heralded by an impending myasthenic crisis (iMC), is a critical condition requiring treatments with rapid ons...
Saved in:
| Main Authors: | Isabelle Kwiedor, Martina Menacher, Monika Ellßel, Markus Naumann, Antonios Bayas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-12-01
|
| Series: | Therapeutic Advances in Neurological Disorders |
| Online Access: | https://doi.org/10.1177/17562864241307687 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efgartigimod as Rescue Medication in a Patient with Therapy-Refractory Myasthenic Crisis
by: Omar Alhaj Omar, et al.
Published: (2024-01-01) -
Fast-acting treatment of myasthenic crisis with efgartigimod from the perspective of the neuro intensive care unit
by: Fangyi Shi, et al.
Published: (2025-02-01) -
Correction: Fast-acting treatment of myasthenic crisis with efgartigimod from the perspective of the neuro intensive care unit
by: Fangyi Shi, et al.
Published: (2025-05-01) -
Thymectomy immediately after myasthenic crisis
by: Martić Vesna, et al.
Published: (2021-01-01) -
Long-term follow-up of patients with non-ischemic cerebral enhancing lesions following endovascular aneurysm treatment: magnetic resonance imaging findings, clinical course, and treatment
by: Monika Ellssel, et al.
Published: (2025-06-01)